Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma
Titel:
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma
Auteur:
Talukder, Rafee Makrakis, Dimitrios Lin, Genevieve Ihsiu Diamantopoulos, Leonidas N. Dawsey, Scott Gupta, Shilpa Carril-Ajuria, Lucia Castellano, Daniel de Kouchkovsky, Ivan Jindal, Tanya Koshkin, Vadim S. Park, Joseph J. Alva, Ajjai Bilen, Mehmet A. Stewart, Tyler F. McKay, Rana R. Tripathi, Nishita Agarwal, Neeraj Vather-Wu, Naomi Zakharia, Yousef Morales-Barrera, Rafael Devitt, Michael E. Cortellini, Alessio Fulgenzi, Claudia Angela Maria Pinato, David J. Nelson, Ariel Hoimes, Christopher J. Gupta, Kavita Gartrell, Benjamin A. Sankin, Alex Tripathi, Abhishek Zakopoulou, Roubini Bamias, Aristotelis Murgic, Jure Fröbe, Ana Rodriguez-Vida, Alejo Drakaki, Alexandra Liu, Sandy Lu, Eric Kumar, Vivek Lorenzo, Giuseppe Di Joshi, Monika Isaacsson-Velho, Pedro Buznego, Lucia Alonso Duran, Ignacio Moses, Marcus Barata, Pedro Sonpavde, Guru Wright, Jonathan L. Yu, Evan Y. Montgomery, Robert Bruce Hsieh, Andrew C. Grivas, Petros Khaki, Ali Raza